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Objective: Autogenous vein is the conduit of choice in patients presenting for infrainguinal arterial reconstruction. Venous
conduit may be limited because of inadequacy or prior utilization. Our group and others use prosthetics to maximize limb
salvage with moderate results. However, in cases where patients present with an isolated popliteal segment that may
extend below the knee, we have performed prosthetic bypasses to this above-knee segment and then used a venous
reconstruction from the native arterial circulation to a more distal outflow tract. In this report, we will analyze our results
using this type of reconstruction in patients who present for limb salvage with no all-autogenous option.
Method: From 1992 to 2000, 27 patients presented for limb salvage with an isolated popliteal artery and inadequate vein
for continuous bypass. There were 106 patients in this period without an isolated popliteal segment or adequate vein who
underwent prosthetic bypass with distal vein cuff or arteriovenous fistula. The vascular registry and patient charts were
reviewed for indication, demographics, and type of composite reconstruction. Outcomes were calculated with use of life
table methods and compared by log rank analysis.
Results: Demographics revealed 16 (59%) men, 16 (59%) patients with diabetes, and 4 (15%) smokers with a mean age of
71 years (range, 51-87 years). The venous reconstructions had the inflow taken from the distal native popliteal artery in
26 (above knee in 8 and below knee in 18) and the peroneal artery in one. The outflow involved the below-knee popliteal
in one (4%), a tibial in 23 (85%), and the dorsalis pedis artery in 3 (11%). Morbidity included bleeding (4%), wound
infection (4%), and limb loss (4%). Mortality occurred in one patient (4%), and no revisions were required in follow-up.
Six late failures were identified, one of which resulted in amputation. Primary patency and limb salvage were 80% and 88%
at 1 year, respectively. For comparison, our results using prosthetic with vein cuff had a 1-year primary patency of 52%
and limb salvage of 92% (P  NS), whereas prosthetic with an arteriovenous fistula was 73% and 84%, respectively (P 
NS).
Conclusions: Composite sequential reconstruction using an isolated popliteal segment as inflow for the distal reconstruc-
tion is an acceptable option in patients presenting for limb salvage reconstruction with limited venous conduit. This type
of reconstruction, when available, may be a better option than pure prosthetic with or without a vein cuff or arteriovenous
fistula. (J Vasc Surg 2002;36:325-9.)
Over the past several decades, limb salvage has im-
proved markedly with use of infrainguinal arterial recon-
struction.1 Our group and others feel that autogenous vein
is the conduit of choice in patients who present with
limb-threatening ischemia. However, the presence of ipsi-
lateral greater saphenous vein has decreased in recent
years.2 This may be the result of both inadequacy or prior
utilization. Autogenous composite (or spliced vein) bypass
also provides reasonable patency rates and allows excellent
limb salvage.3 When a spliced vein option is not available,
we have used prosthetic conduit to an isolated popliteal
artery segment as described by Mannick et al.4 By using
adjuncts such as a distal arteriovenous fistula (DAVF) or a
distal vein cuff (DVC), we have had acceptable results with
prosthetic bypasses to the below-knee popliteal or tibial
vessels.5 However, in cases where patients present with an
isolated popliteal segment that may extend below the knee,
we have performed prosthetic bypasses to this above-knee
segment and then used a venous reconstruction from the
native arterial circulation to a more distal outflow tract.
This technique is not a new concept. It was originally
described by DeLaurentis and Friedmann6 in five patients
nearly 30 years ago. Recent reports have detailed series that
do not differentiate whether the distal vein bypass origi-
nates from the prosthetic graft hood or the native ar-
tery.7-10 In this report, we analyze our results using this
type of “composite sequential” reconstruction in patients
who present for limb salvage with no all-autogenous option
and require use of the native popliteal artery segment for
adequate revascularization. We also compare outcomes
with this technique to prosthetic bypass taken below the
knee with either a DVC or a DAVF as an adjunct as well as
to composite autogenous (or spliced vein) reconstructions.
PATIENTS AND METHODS
From 1992 to 2000, all patients presenting with lower
extremity ischemia to Albany Medical Center were entered
prospectively into a vascular surgery registry. This includes
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4421 infrainguinal arterial reconstructions. When limb sal-
vage was the indication for surgery (rest pain or tissue loss),
we identified 3744 patients. Of these, spliced vein was used
in 536 cases. We performed a retrospective review of the
remaining 3208 patients finding all whose indication for
surgery was limb salvage, whose superficial femoral artery
was occluded leaving an isolated popliteal artery, and who
had inadequate vein for a continuous bypass. This group of
patients was called the composite sequential group. These
patients all received an 8-mm polytetrafluoroethylene
(PTFE) graft without an adjunct such as a DVC or a DAVF
to the above-knee popliteal artery. The vein bypass origi-
nated from a native artery distal to prosthetic bypass. Both
bypasses were done at the same setting in all cases. No
anticoagulation was used postoperatively unless required
for other medical reasons. The specific indication, demo-
graphics, type of composite reconstruction, and outcome
were determined. Patency and limb salvage rates were
calculated by life table methods. Data were then obtained
from all infrageniculate prosthetic (6-mm PTFE) bypasses
accompanied by either a DVC or an DAVF as well as from
all composite autogenous (spliced vein) bypasses done for
arterial limb ischemia. All patients with a prosthetic bypass
having a DAVF or DVC were maintained on warfarin for
anticoagulation. Comparisons were performed using log
rank analysis between these other three groups and the
composite sequential bypasses. Statistical significance was
assumed for P  .05. Early in this series, we preferentially
used prosthetic bypass with a DVC or DAVF in the setting
of limb-threatening ischemia and no all-autogenous op-
tion. Over the past 5 years, and especially over the last 2
years, we have relied more on a composite sequential bypass
when possible for a theoretical advantage over pure pros-
thetic. That is, we perceived that the autogenous portion
might improve limb salvage and patency because it was
below the knee and the prosthetic was not.
RESULTS
During this 9-year review, 27 patients were identified
who met the inclusion criteria. The mean age was 71 years
(range, 51-87 years). Sixteen patients (59%) were men, 16
(59%) had diabetes, and 4 (15%) were active smokers. As far
as indication for the procedure, 18 (67%) had a nonhealing
ulcer, 7 (26%) had ischemic gangrene, and 2 (7%) had
ischemic rest pain. For 26 of 27 patients, prior procedures
had failed. The inflow and outflow arteries are detailed in
Table I. The proximal prosthetic bypasses originated most
often from the common femoral artery (n 21, 78%). Four
(15%) originated from the proximal superficial femoral
artery, and 2 (7%) from a prosthetic inflow graft in the
groin. With regard to distal vein bypasses, the majority
originated from the below-knee popliteal artery (n  18,
67%), thus utilizing the native vessel as a conduit crossing
the knee joint. Eight of these grafts began in the popliteal
artery above the knee but were at least 5-cm distal to the
prosthetic bypass. One vein graft originated from the prox-
imal peroneal artery. All prosthetic grafts ended without a
DVC or a DAVF at the above-knee popliteal artery. The
vein grafts were disbursed evenly among the various tibial
vessels. Three vein grafts were sewn to the dorsalis pedis
artery. All PTFE bypasses were 8 mm in diameter and 25 of
27 (93%) vein conduits were harvested from the arm,
whereas 2 of 27 were lesser saphenous vein.
One patient died during the 30 days postoperatively,
giving a mortality rate of 3.7%. Two vein graft occlusions
occurred in the perioperative period, one at 20 days and the
other at 40 days after surgery. The prosthetic grafts re-
mained patent and the distal vein was not revised. Neither
of these occlusions were associated with limb loss. One
patient had hemodynamic failure of the bypass, which
resulted in limb loss at 60 days post surgery. One patient
had a wound infection, which required reoperation for
de´bridement, and one patient had reoperation for bleed-
ing. In long-term follow-up, one prosthetic graft occluded
at 20 months with a patent vein graft. There was no further
intervention because the patient remained asymptomatic.
The mean standard deviation time to follow-up was 12
4 months (range, 1-79 months). The short follow-up may
be secondary to the fact that most of the composite sequen-
tial bypasses were done later in this series.
Table II demonstrates primary patency,Table III sec-
ondary patency, Table IV limb salvage, and Table V survival
in these 27 patients. At 1 year post procedure, there were
no revisions such that primary and secondary patencies
were both 91%. To determine whether the use of prosthetic
conduit with a DVC or a DAVF was a better option than a
composite sequential procedure, we used the data from a
report already published by our group that compared these
two PTFE conduits.5 During this period, 47 bypasses were
created with prosthetic and a DAVF, whereas 59 were done
with prosthetic and a DVC. In total, these three types of
bypasses encompassed only 4% of all lower extremity limb-
salvage procedures at our institution. The composite se-
quential option was available in 20% of these patients who
lacked adequate venous conduit. In our series, prosthetic
bypass using a DVC in the setting of limb-threatening
ischemia had a 1-year primary patency of 52% and a limb-
salvage rate of 92%. These results did not differ significantly
Table I. Inflow and outflow arteries
Proximal Distal
Inflow
Common femoral 21 NA
Superficial femoral 4 NA
Graft 2 NA
AK popliteal NA 8
BK popliteal NA 18
Peroneal NA 1
Outflow
AK popliteal 27 NA
BK popliteal NA 1
Anterior tibial NA 10
Dorsalis pedis NA 3
Posterior tibial NA 7
Peroneal NA 6
AK, Above knee; BK, below knee; NA, not applicable.
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from those of the composite sequential option. When a
prosthetic bypass was used with a DAVF placed distally,
again in the setting of limb-threatening ischemia, 1-year
primary patency was 73% with a limb-salvage rate of 84%.
Again, these results did not differ significantly from those of
the composite sequential series.
We further compared the data to our 536 composite
autogenous (or spliced vein) bypasses done in the same
period for patency, salvage, and survival. No significant
differences were identified here as well (unpublished data,
SPR).
DISCUSSION
Optimal management of infrainguinal occlusive disease
is dependent upon the presence of ipsilateral greater saphe-
nous vein. Use of this vein in an in situ or excised conıgu-
ration has regularly demonstrated primary patency rates
near 70% at 5 years.1,11-13 Unfortunately, the prior use of
Table II. Primary patency
Interval
(mo)
Grafts
entered
Occlusions/
revisions (n)
Withdrawn
(n)
Patency interval /
cumulative
Standard
error
Composite sequential
0-1 27 1 9 0.956/0.956 0.039
2-12 17 2 9 0.840/0.803 0.087
13-24 6 1 2 0.800/0.642 0.157
25-36 3 0 0 1.000/0.642 0.222
DAVF
0-1 47 6 6 0.864/0.864 0.047
2-12 35 5 5 0.846/0.731 0.064
13-24 25 8 4 0.652/0.477 0.069
25-36 13 0 2 1.000/0.477 0.096
DVC
0-1 59 2 11 0.963/0.963 0.024
2-12 46 19 9 0.542/0.522 0.053
13-24 18 5 6 0.667/0.348 0.066
25-36 7 0 4 1.000/0.348 0.106
Spliced
0-1 536 64 76 0.871/0.871 0.014
2-12 396 81 131 0.755/0.658 0.019
13-24 184 23 47 0.857/0.564 0.027
25-36 114 7 29 0.930/0.524 0.034
DAVF, PTFE conduit with a distal arteriovenous fistula5; DVC, PTFE conduit with a distal vein cuff 5; PTFE, polytetrafluoroethylene.
*Log rank analysis reveals no difference between curves.
Table III. Secondary patency
Interval
(mo)
Grafts
entered
Occlusions
(n)
Withdrawn
(n)
Patency interval/
cumulative
Standard
error
Composite sequential
0-1 27 1 9 0.956/0.956 0.039
2-12 17 2 9 0.840/0.803 0.087
13-24 6 1 2 0.800/0.642 0.157
25-36 3 0 0 1.000/0.642 0.222
DAVF
0-1 47 6 6 0.864/0.864 0.047
2-12 35 5 5 0.846/0.731 0.064
13-24 25 8 4 0.652/0.477 0.069
25-36 13 0 2 1.000/0.477 0.096
DVC
0-1 59 1 12 0.981/0.981 0.018
2-12 46 19 8 0.548/0.537 0.054
13-24 19 4 6 0.750/0.403 0.071
25-36 9 0 3 1.000/0.403 0.104
Spliced
0-1 536 38 83 0.923/0.923 0.011
2-12 415 45 152 0.867/0.801 0.018
13-24 218 22 57 0.884/0.708 0.026
25-36 139 5 42 0.958/0.678 0.033
DAVF, PTFE conduit with a distal arteriovenous fistula5; DVC, PTFE conduit with a distal vein cuff 5; PTFE, polytetrafluoroethylene.
*Log rank analysis reveals no difference between curves.
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vein for cardiac surgery, lower extremity revascularization,
or dialysis access has increased the number of patients who
have inadequate vein to complete an appropriate bypass.
Veith et al14 demonstrated that use of the superficial fem-
oral artery and popliteal artery for inflow may provide
excellent results for infrainguinal reconstruction, decreas-
ing the length of vein required. However, in patients with
significant superficial femoral artery disease it may not be
possible to use this distal inflow source. In comparison, our
group and others have reported acceptable results with
spliced vein reconstruction for limb-threatening ischemia.3
Unfortunately, this procedure may require multiple surgi-
cal fields with a consequent increase in morbidity.15 In
some instances, lack of suitable autogenous conduit may
make this option impossible. It is in this group that we have
turned to a prosthetic conduit. However, the long-term
patency of this reconstruction is somewhat poor. Veith et
al,16 in a multicenter trial evaluating obligatory prosthetic
Table IV. Limb salvage
Interval
(mo)
Limbs at
risk (n)
Amputations
(n)
Withdrawn
(n)
Patency interval/
cumulative
Standard
error
Composite sequential
0-1 27 1 8 0.957/0.957 0.038
2-12 18 1 10 0.923/0.883 0.071
13-24 7 0 3 1.000/0.883 0.114
25-36 4 0 0 1.000/0.883 0.151
DAVF
0-1 47 3 8 0.930/0.930 0.036
2-12 36 3 8 0.906/0.843 0.056
13-24 25 2 10 0.900/0.759 0.075
25-36 13 0 0 1.000/0.759 0.103
DVC
0-1 59 3 7 0.946/0.946 0.029
2-12 49 1 36 0.968/0.915 0.038
13-24 12 0 11 1.000/0.915 0.077
25-36 1 0 0 1.000/0.915 0.266
Spliced
0-1 536 17 103 0.965/0.965 0.008
2-12 416 13 183 0.960/0.926 0.012
13-24 220 7 71 0962/0.891 0.020
25-36 142 3 43 0.975/0.869 0.026
DAVF, PTFE conduit with a distal arteriovenous fistula5; DVC, PTFE conduit with a distal vein cuff 5; PTFE, polytetrafluoroethylene.
*Log rank analysis reveals no difference between curves.
Table V. Patient survival
Interval
(mo)
Patients at risk
(n)
Deaths
(n)
Withdrawn
(n)
Survival interval/
cumulative
Standard
error
Composite sequential
0-1 27 1 8 0.957/0.957 0.038
2-12 18 2 10 0.846/0.809 0.083
13-24 6 0 3 1.000/0.809 0.144
25-36 3 0 0 1.000/0.809 0.204
DAVF
0-1 45 3 9 0.926/0.926 0.038
2-12 33 3 7 0.898/0.832 0.059
13-24 23 2 8 0.895/0.744 0.079
25-36 13 1 1 0.920/0.685 0.107
DVC
0-1 59 1 13 0.981/0.981 0.018
2-12 45 2 25 0.938/0.921 0.039
13-24 18 0 9 1.000/0.921 0.061
25-36 9 1 4 0.857/0.789 0.121
Spliced
0-1 536 100 21 0.957/0.957 0.009
2-12 415 164 33 0.901/0.862 0.016
13-24 218 64 15 0.919/0.793 0.025
25-36 139 42 5 0.958/0.759 0.032
DAVF, PTFE conduit with a distal arteriovenous fistula; DVC, PTFE conduit with a distal vein cuff; PTFE, polytetrafluorethylene.
*Log rank analysis reveals no difference between curves.
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femorotibial bypass, reported a 3-year primary patency of
18%. This can be improved with a DAVF and anticoagula-
tion. Ascer et al17 found 3-year patency with PTFE con-
duits to be 62% in this setting. In selected patients, we
employ PTFE bypass to an above-knee isolated popliteal
segment. However, in patients with significant infragenicu-
late arterial occlusive disease presenting with limb-threat-
ening ischemia, a bypass to an isolated popliteal segment
may not be adequate for tissue healing. This leaves the
surgeon with numerous secondary options when faced with
no single autogenous resource. Dardik et al18 have demon-
strated 1- and 4-year patencies using umbilical vein with
distal arteriovenous fistulas to a crural vessel of 40% and
25%, respectively. Alternatively, one can perform a compos-
ite sequential bypass. This is not a new concept. Verta19
demonstrated a tibial reconstruction using a composite
sequential technique and had patencies of 81% at 2 years
and 72% at 4 years. Bastounis et al20 also demonstrated that
composite grafts of PTFE and saphenous vein were signif-
icantly superior to PTFE grafts alone for infrageniculate
reconstruction and limb salvage. McCarthy et al7 per-
formed 67 composite sequential reconstructions with limb
salvage of 84% at 2 years and 70% at 4 years. Their primary
patencies at 1, 2, and 3 years were 72%, 64%, and 48%,
respectively. These series all relied on obtaining the distal
vein bypass from the prosthetic graft and not a distal native
artery.
In hope of finding reconstruction options that would
theoretically be advantageous, we have chosen a type of
composite sequential reconstruction that uses a prosthetic
(PTFE) above the knee to an isolated popliteal segment in
combination with a vein bypass from a more distal arterial
segment. Conceptually, we believed that using the native
popliteal or tibial artery as the inflow source for the distal
portion of this reconstruction might allow for continued
patency even in the face of inflow compromise. This would
theoretically maximize the flow through the prosthetic
conduit while optimizing pulsatile blood flow to the isch-
emic area. Although the follow-up in this series is short, the
early results are promising. In addition, this type of recon-
struction may have patency and limb salvage comparable to
and possibly better than those of prosthetic reconstructions
to tibial vessels, and without the need for systemic antico-
agulation. However, there was no difference in overall
survival, suggesting that anticoagulation long-term did not
affect mortality in these patients. As compared with bypass
to an isolated popliteal segment, the composite sequential
technique, in our opinion, is a way of achieving maximal
improvement of tissue perfusion. This said, we would by-
pass directly to an isolated popliteal artery segment if no
vein were available for a distal reconstruction.
In conclusion, infrageniculate arterial reconstruction
with use of an isolated popliteal segment for composite
sequential reconstruction is an acceptable option in patients
presenting for limb-salvage reconstruction in conjunction
with limited venous conduit. This type of reconstruction
maximizes arterial flow to the affected tissue bed and is an
option to prosthetic infrageniculate reconstruction with or
without adjunct.
REFERENCES
1. Shah DM, Darling RC III, Chang BB, Fitzgerald KM, Paty PSK,
Leather RP. Long-term results of in-situ saphenous vein bypass. Anal-
ysis of 2058 cases. Ann Surg 1995;222:438-6.
2. Chang BB, Shah DM, Leather RP, Darling RC III. Finding autogenous
veins for reoperative lower extremity bypasses: limitations of veins other
than the greater saphenous. Semin Vasc Surg 1994;7:173-7.
3. Chang BB, Darling RC III, Bock DE, Shah DM, Leather RP. The use
of spliced vein bypasses for infrainguinal arterial reconstruction. J Vasc
Surg 1995;21:403-10.
4. Mannick JA, Jackson BT, Coffman JD, Hume DM. Success of bypass
vein grafts in patients with isolated popliteal artery segments. Surgery
1967;61:17-25.
5. Kreienberg PB, Darling RC III, Chang BB, Paty PSK, Lloyd WE, Shah
DM. Adjunctive techniques to improve patency of distal prosthetic
bypass grafts: polytetrafluoroethylene with remote arteriovenous fistu-
lae versus vein cuffs. J Vasc Surg 2000;31:696-701.
6. DeLaurentis DA, Friedmann P. Sequential femoropopliteal bypasses:
Another approach to the inadequate saphenous vein problem. Surgery
1972;71:400-4.
7. McCarthy WJ, Pearce WH, Flinn WR, McGee GS, Wang R, Yao JST.
Long-term evaluation of composite sequential bypass for limb-threat-
ening ischemia. J Vasc Surg 1992;15:761-70.
8. Lamberth WC Jr, Karkow WS. Sequential femoro-popliteal-tibial by-
pass grafting: operative technique and results. Ann Thoracic Surg
1986;42(6 Suppl):S31-5.
9. Flinn WR, Flanigan DP, Verta MJ Jr, Bergan JJ, Yao JS Jr. Sequential
femoral-tibial bypass for severe limb ischemia. Surgery 1980;88:357-65.
10. Alexander JJ, Wells KE, Piotrowski J. The role of composite sequential
bypassin the treatment of multilevel infrainguinal arterial occlusive
disease. Am J Surg 1996;172:118-22.
11. Bergamini TM, Towne JB, Bandyk DF, Seabrook GR, Schmitt DD.
Experience with in situ saphenous vein bypass during 1981 to 1989:
determinant factors of long-term patency. J Vasc Surg 1991;13:137-47.
12. Taylor LM, Edwards JM, Porter JM. Present status of reversed vein
bypass grafting: five-year results of a modern series. J Vasc Surg 1990:
11:193-206.
13. Fogle MA, Whittemore AD, Couch NP, Mannick JA. A comparison of
in situ and reversed saphenous vein grafts for infrainguinal reconstruc-
tions. J Vasc Surg 1987;5:46-52.
14. Veith FJ, Gupta SK, Samson RH, Flores SW, Janko G, Scher LA.
Superficial femoral and popliteal arteries as inflow sites for distal by-
passes. Surgery 1981;90:980-90.
15. Kreienberg PB, Darling RC III, Chang BB, Champagne BJ, Paty PSK,
Roddy SP, et al. Early results of a prospective randomized trial of spliced
vein versus PTFE with a distal vein cuff for limb threatening ischemia. J
Vasc Surg 2002;35:299-306.
16. Veith FJ, Gupta SK, Ascer E, White-Flores S, Samson RH, Scher LA, et
al. Six-year prospective multicenter randomized comparison of autolo-
gous saphenous vein and expanded polytetrafluorethylene grafts in
infrainguinal arterial reconstructions. J Vasc Surg 1986;3:104-14.
17. Ascer E, Gennaro M, Pollina RM, Ivanov M, Yorkovich WR, Ivanov M,
et al. Complementary distal arteriovenous fistula and deep vein inter-
position: a five-year experience with a new technique to improve infr-
apopliteal prosthetic bypass patency. J Vasc Surg 1996;24(1):134-43.
18. Dardik H, Miller N, Dardik A, Ibrahim IM, Sussman B, Berry SM, et al.
A decade of experience with the glutaraldehyde-tanned human umbil-
ical cord vein graft for revascularization of the lower limb. J Vasc Surg
1988;7:336-46.
19. Verta MJ. Composite sequential bypasses to the ankle and beyond for
limb salvage. J Vasc Surg 1984;1:381-6.
20. Bastounis E, Georgopoulos S, Maltezos C, Alexiou D, Chiotopoulos D,
Bramis J. PTFE-vein composite grafts for critical limb ischaemia: a
valuable alternative to all-autogenous infrageniculate reconstructions.
Eur J Vasc Endovasc Surg 1999;18:127-32.
Submitted Oct 01, 2001; accepted March 26, 2002.
JOURNAL OF VASCULAR SURGERY
Volume 36, Number 2 Roddy et al 329
